What is your escalation strategy for chronic GvHD?
1
1 AnswersMednet Member
Hematology · Dana-Farber Cancer Institute
There are now several available options for steroid resistant cGVHD. The old standbys - ECP and rituxan are useful in about 30% of patients. Ibrutinib was the first new drug to get FDA approval. Unfortunately, I don't think the real-world experience is anywhere near as good as the trial (Chin et al....